Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Manifestaciones Cutáneas de Covid-19
Manifestaciones Cutáneas de Covid-19
Recalcati, S. (2020). Cutaneous manifestations in COVID-19: a first perspective. Journal of the European Academy of Dermatology and
PRIMERAS OBSERVACIONES CUTÁNEAS EN PACIENTES CON
COVID-19
Recalcati S. Cutaneous manifestations in COVID-19: A first perspective. J Eur Acad Dermatol Venereol. 2020;34:e212–e213.
Hedou M., Carsuzaa F., Chary E., Hainaut E., Cazenave-Roblot F., Masson Regnault M
Comment on ‘Cutaneous manifestations in COVID-19: A first perspective’ by Recalcati S. J Eur Acad Dermatology Venereol. 2020;34:e299–e300.
Seque CA, Enokihara MMSES, Porro AM, Tomimori J. Skin manifestations associated with COVID-19. An Bras Dermatol. 2022 Jan-Feb;97(1):75-88. doi:
10.1016/j.abd.2021.08.002. Epub 2021 Nov 10. PMID: 34857407; PMCID: PMC8577992.
FISIOPATOLOGÍA
Seque CA, Enokihara MMSES, Porro AM, Tomimori J. Skin manifestations associated with COVID-19. An Bras
Dermatol. 2022 Jan-Feb;97(1):75-88. doi: 10.1016/j.abd.2021.08.002. Epub 2021 Nov 10. PMID: 34857407; PMCID:
PATRONES DERMATOLÓGICOS DESCRITOS
6%
19%
375 pacientes con covid-19 +
manifestaciones cutáneas de 2 semanas de
evolución
9%
47%
Fotografías de las lesiones 4 19%
dermatólogos clasificación
en 5 patrones dermatológicos
observados Pseudo chil-blain Vesicular
Urticarial Maculopapular
Livedo/Necrosis
Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus
study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
EXANTEMA MACULOPAPULAR
Genovese G, Moltrasio C, Berti E, Marzano A, V: Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology 2021;237:1-12. doi:
10.1159/000512932
Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus
study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
EXANTEMA MACULOPAPULAR (47%)
Más frecuente
Primeros días del cuadro y dura 7-10 días
COVID-19 moderado
Exantema morbiliforme Manchas y pápulas eritematosas
Topografía: Tronco y extremidades
Prurito leve a moderado
Genovese G, Moltrasio C, Berti E, Marzano A, V: Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology 2021;237:1-12. doi:
10.1159/000512932
Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus
study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
Variante intertriginosa flexural
Tipo Pitiriasis rosada de Gibert Patrón folicular
Reactivación HVH6
Tipo Eritema multiforme Patrón Moluscoide
EXANTEMA MACULOPAPULAR (47%)
No específico
Farmacodermia
Exantemas virales distintos
VHH-6
Otros síntomas de COVID-19
Tto. sintomático
Esteroides tópicos o sistémicos
Genovese G, Moltrasio C, Berti E, Marzano A, V: Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology 2021;237:1-12. doi:
10.1159/000512932
Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus
study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
ERITEMA PERNIO-LIKE
Chilblain o Eritema Pernio o Sabañón
“clásico”
Respuesta vascular anormal al frío
vasoconstricción cutánea hipoxia tisular
inflamación ¿asociado a
crioglobulinas?
Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus
study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
ERITEMA PERNIO LIKE (19%)
No asociado a frío
Pacientes jóvenes (M12 años)
Caminar descalzos*
T: Dedos pies > manos, codos, cara
lateral del pie
M: Manchas eritematovioláceas y
edema
Prurito ++ o asx
Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus
study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus
study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
ERITEMA PERNIO LIKE (19%)
Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus
study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
EXANTEMA VESICULAR
EXANTEMA VESICULAR(9%)
Genovese G, Moltrasio C, Berti E, Marzano A, V: Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology 2021;237:1-12. doi:
10.1159/000512932
Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus
study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
EXANTEMA VESICULAR(9%)
Genovese G, Moltrasio C, Berti E, Marzano A, V: Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology 2021;237:1-12. doi:
10.1159/000512932
Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus
study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
EXANTEMA URTICARIFORME
URTICARIAL (19%)
Genovese G, Moltrasio C, Berti E, Marzano A, V: Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology 2021;237:1-12. doi:
10.1159/000512932
Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus
study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
URTICARIAL (19%)
Genovese G, Moltrasio C, Berti E, Marzano A, V: Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology 2021;237:1-12. doi:
10.1159/000512932
Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus
study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71-77. doi:10.1111/bjd.19163
LÍVEDO/NECROSIS (6%)
LÍVEDO/NECROSIS (6-7%)
Menos frecuentes
Lívedo reticularis
COVID-19 graves
Lívedo racemosa
Tercera edad y comorbilidades Purpura retiforme
Asociadas a tabaquismo
Mal pronóstico Correlación con daño vascular
sistémico
Genovese G, Moltrasio C, Berti E, Marzano A, V: Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology 2021;237:1-12. doi:
10.1159/000512932
LÍVEDO RETICULARIS
Genovese G, Moltrasio C, Berti E, Marzano A, V: Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology 2021;237:1-12. doi:
10.1159/000512932
Khalil S, Hinds BR, Manalo IF, Vargas IM, Mallela S, Jacobs R. Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection. JAAD Case
Rep. 2020;6(9):871-874. doi:10.1016/j.jdcr.2020.07.014
LÍVEDO
RACEMOSA/PÚRPURA
RETIFORME
Inflamación IL-6
activación de plaquetas e
inhibición de plasmina
Daño endotelial activación de
complemento activación de
trombina y fibrinógeno
NET Inflamación local y
microtrombosis
Genovese G, Moltrasio C, Berti E, Marzano A, V: Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology 2021;237:1-12. doi:
10.1159/000512932
Khalil S, Hinds BR, Manalo IF, Vargas IM, Mallela S, Jacobs R. Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection. JAAD Case
Rep. 2020;6(9):871-874. doi:10.1016/j.jdcr.2020.07.014
Khalil S, Hinds BR, Manalo IF, Vargas IM, Mallela S, Jacobs R. Livedo reticularis as a presenting sign of
severe acute respiratory syndrome coronavirus 2 infection. JAAD Case Rep. 2020;6(9):871-874.
doi:10.1016/j.jdcr.2020.07.014
LESIONES PURPÚRICAS
LESIONES PURPÚRICAS O VASCULÍTICAS
Menos del 5%
Manifestación cutánea de COVID-19 con mayor mortalidad
Tercera edad y COVID-19 grave
Correlación con daño endotelial sistémico
Vasculitis leucocitoclástica
EFLUVIO TELÓGENO
EFLUVIO TELÓGENO
+ Fiebre